119 related articles for article (PubMed ID: 12590317)
1. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
[TBL] [Abstract][Full Text] [Related]
2. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.
Ammori JB; Colletti LM; Zalupski MM; Eckhauser FE; Greenson JK; Dimick J; Lawrence TS; McGinn CJ
J Gastrointest Surg; 2003; 7(6):766-72. PubMed ID: 13129554
[TBL] [Abstract][Full Text] [Related]
3. Concomitant radiochemotherapy with 5-FU and cisplatin for invasive bladder cancer. Acute toxicity and first results.
Birkenhake S; Leykamm S; Martus P; Sauer R
Strahlenther Onkol; 1999 Mar; 175(3):97-101. PubMed ID: 10093610
[TBL] [Abstract][Full Text] [Related]
4. An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).
Berlin JD; Feng Y; Catalano P; Abbruzzese JL; Philip PA; McWilliams RR; Lowy AM; Benson AB; Blackstock AW
Oncology; 2018; 94(1):39-46. PubMed ID: 29040974
[TBL] [Abstract][Full Text] [Related]
5. Aggressive secondary surgery for local recurrence of pancreatic cancer.
Shimoike N; Fujikawa T; Maekawa H; Tanaka A
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23774708
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.
Li D; Frazier M; Evans DB; Hess KR; Crane CH; Jiao L; Abbruzzese JL
J Clin Oncol; 2006 Apr; 24(11):1720-8. PubMed ID: 16520463
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy.
Lautenschlaeger S; Dumke C; Exeli L; Hauswald H; Engenhart-Cabillic R; Eberle F
Strahlenther Onkol; 2023 Nov; 199(11):982-991. PubMed ID: 37428207
[TBL] [Abstract][Full Text] [Related]
8. Weekly cisplatin or gemcitabine concomitant with radiation in the management of locally advanced carcinoma cervix: results from an observational study.
Verma AK; Arya AK; Kumar M; Kumar A; Gupta S; Sharma D; Rath G
J Gynecol Oncol; 2009 Dec; 20(4):221-6. PubMed ID: 20041098
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma.
Ma JH; Patrut E; Schmidt J; Knaebel HP; Büchler MW; Märten A
World J Gastroenterol; 2005 Mar; 11(10):1521-8. PubMed ID: 15770730
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer--new insights into systemic therapy.
Neijt JP
Eur J Cancer; 1995; 31A(5):823-4. PubMed ID: 7640067
[No Abstract] [Full Text] [Related]
11.
Schneider T; Zwicker F; Huber PE; Debus J; Hauswald H
In Vivo; 2023; 37(5):1951-1959. PubMed ID: 37652498
[TBL] [Abstract][Full Text] [Related]
12. From Cisplatin-Containing Sequential Radiochemotherapy towards Concurrent Treatment for Patients with Inoperable Locoregional Non-Small Cell Lung Cancer: Still Unanswered Questions.
Koning CC; Belderbos JS; Uitterhoeve AL
Chemother Res Pract; 2010; 2010():506047. PubMed ID: 22482052
[TBL] [Abstract][Full Text] [Related]
13. Targeted irradiation in an autochthonous mouse model of pancreatic cancer.
Tesson M; Stevenson K; Karim SA; Nixon C; Chalmers AJ; Sansom OJ; O'Neill E; Jones K; Morton JP
Dis Model Mech; 2024 Mar; 17(3):. PubMed ID: 38421046
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.
Walker AJ; Alcorn SR; Narang AK; Nugent KM; Wild AT; Herman JM; Tran PT
Curr Probl Cancer; 2013; 37(5):301-12. PubMed ID: 24331186
[TBL] [Abstract][Full Text] [Related]
15. Combining Cisplatin with Different Radiation Qualities-Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis.
Runge R; Reissig F; Herzog N; Oehme L; Brogsitter C; Kotzerke J
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139846
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for pancreatic cancer - A systematic review of prospective data.
Shouman MA; Fuchs F; Walter F; Corradini S; Westphalen CB; Vornhülz M; Beyer G; Andrade D; Belka C; Niyazi M; Rogowski P
Clin Transl Radiat Oncol; 2024 Mar; 45():100738. PubMed ID: 38370495
[TBL] [Abstract][Full Text] [Related]
17. The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
Brunner TB; Scott-Brown M
Radiat Oncol; 2010 Jul; 5():64. PubMed ID: 20615227
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiation in pancreatic adenocarcinoma: a literature review.
Roy R; Maraveyas A
Oncologist; 2010; 15(3):259-69. PubMed ID: 20203172
[TBL] [Abstract][Full Text] [Related]
19. Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
Tinkl D; Grabenbauer GG; Golcher H; Meyer T; Papadopoulos T; Hohenberger W; Sauer R; Brunner TB
Strahlenther Onkol; 2009 Sep; 185(9):557-66. PubMed ID: 19756421
[TBL] [Abstract][Full Text] [Related]
20. [The role of radiation therapy in treatment of pancreatic cancer from the viewpoint of radio-oncologists].
Timke C; Debus JP
Radiologe; 2009 Feb; 49(2):149-53. PubMed ID: 19156394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
